This startup develops products based on bacteriophages for biological control of bacteria and biofilms of interest to the medical, veterinary and oil industries. In addition to biological control, they work on the production of recombinant antigens that can be used in diagnostic kits targeting arboviruses, such as dengue, Zika, and Mayaro.
BUSINESS MODEL: Customization of phage gene panel to attack biofilms of interest and production of antigens and diagnostic kits (B2B)
PRODUCT: In development
For further information, please contact us.
Back to Investors page